Preventing Chronic Disease in the Workplace: A Workshop Report and Recommendations

Chronic disease is the leading cause of death in the United States. Risk factors and work conditions can be addressed through health promotion aimed at improving individual health behaviors; health protection, including occupational safety and health interventions; and efforts to support the work–family interface. Responding to the need to address chronic disease at worksites, the National Institutes of Health and the Centers for Disease Control and Prevention convened a workshop to identify research priorities to advance knowledge and implementation of effective strategies to reduce chronic disease risk. Workshop participants outlined a conceptual framework and corresponding research agenda to address chronic disease prevention by integrating health promotion and health protection in the workplace

Study protocol: a randomized controlled trial of a computer-based depression and substance abuse intervention for people attending residential substance abuse treatment

Background: A large proportion of people attending residential alcohol and other substance abuse treatment have a co-occurring mental illness. Empirical evidence suggests that it is important to treat both the substance abuse problem and co-occurring mental illness concurrently and in an integrated fashion. However, the majority of residential alcohol and other substance abuse services do not address mental illness in a systematic way. It is likely that computer delivered interventions could improve the ability of substance abuse services to address co-occurring mental illness. This protocol describes a study in which we will assess the effectiveness of adding a computer delivered depression and substance abuse intervention for people who are attending residential alcohol and other substance abuse treatment. Methods/Design. Participants will be recruited from residential rehabilitation programs operated by the Australian Salvation Army. All participants who satisfy the diagnostic criteria for an alcohol or other substance dependence disorder will be asked to participate in the study. After completion of a baseline assessment, participants will be randomly assigned to either a computer delivered substance abuse and depression intervention (treatment condition) or to a computer-delivered typing tutorial (active control condition). All participants will continue to complete The Salvation Army residential program, a predominantly 12-step based treatment facility. Randomisation will be stratified by gender (Male, Female), length of time the participant has been in the program at the commencement of the study (4 weeks or less, 4 weeks or more), and use of anti-depressant medication (currently prescribed medication, not prescribed medication). Participants in both conditions will complete computer sessions twice per week, over a five-week period. Research staff blind to treatment allocation will complete the assessments at baseline, and then 3, 6, 9, and 12 months post intervention. Participants will also complete weekly self-report measures during the treatment period. Discussion. This study will provide comprehensive data on the effect of introducing a computer delivered, cognitive behavioral therapy based co-morbidity treatment program within a residential substance abuse setting. If shown to be effective, this intervention can be disseminated within other residential substance abuse programs. Trial registration. Australia and New Zealand Clinical Trials Register (ANZCTR): ACTRN12611000618954

Transmission of Yellow Fever Vaccine Virus Through Blood Transfusion and Organ Transplantation in the USA in 2021: Report of an Investigation

BACKGROUND: In 2021, four patients who had received solid organ transplants in the USA developed encephalitis beginning 2-6 weeks after transplantation from a common organ donor. We describe an investigation into the cause of encephalitis in these patients. METHODS: From Nov 7, 2021, to Feb 24, 2022, we conducted a public health investigation involving 15 agencies and medical centres in the USA. We tested various specimens (blood, cerebrospinal fluid, intraocular fluid, serum, and tissues) from the organ donor and recipients by serology, RT-PCR, immunohistochemistry, metagenomic next-generation sequencing, and host gene expression, and conducted a traceback of blood transfusions received by the organ donor. FINDINGS: We identified one read from yellow fever virus in cerebrospinal fluid from the recipient of a kidney using metagenomic next-generation sequencing. Recent infection with yellow fever virus was confirmed in all four organ recipients by identification of yellow fever virus RNA consistent with the 17D vaccine strain in brain tissue from one recipient and seroconversion after transplantation in three recipients. Two patients recovered and two patients had no neurological recovery and died. 3 days before organ procurement, the organ donor received a blood transfusion from a donor who had received a yellow fever vaccine 6 days before blood donation. INTERPRETATION: This investigation substantiates the use of metagenomic next-generation sequencing for the broad-based detection of rare or unexpected pathogens. Health-care workers providing vaccinations should inform patients of the need to defer blood donation for at least 2 weeks after receiving a yellow fever vaccine. Despite mitigation strategies and safety interventions, a low risk of transfusion-transmitted infections remains. FUNDING: US Centers for Disease Control and Prevention (CDC), the Biomedical Advanced Research and Development Authority, and the CDC Epidemiology and Laboratory Capacity Cooperative Agreement for Infectious Diseases

Role of integrated knowledge translation in developing and implementing a multi-component infant feeding intervention: Insights from the CHErIsH study

This article provides an overview and insights from the process of using integrated knowledge translation in developing and implementing the Choosing Healthy Eating for Infant Health (CHErIsH) intervention. Integrated knowledge translation involves collaboration between researchers and research users in the research process, including shaping the research questions, interpreting the results and helping to disseminate the research results (Graham and Tetroe, 2009). The central premise of integrated knowledge translation is that involving knowledge users as equal partners alongside researchers will lead to research that is more relevant to, and more likely to be useful to, the knowledge users (Canadian Institutes of Health Research (CIHR), 2012).peer-reviewe

Conceptualising marine biodiversity mainstreaming as an enabler of regional sustainable blue growth: the case of the European Atlantic area

After recognizing the importance of marine and coastal resources and the use of marine space for economic growth, the European Union (EU) created and implemented a long-term Blue Economy (BE) strategy that supports the development of traditional and emerging marine and maritime sectors, aiming at the enhancement of Blue Growth (BG). However, despite the existence of a robust policy framework that supports the expansion of BE sectors at both an EU Sea Basin and state level, scholars have been sceptical as to whether the pursuit of BG adequately addresses the challenges that usually come with economic development, including those of climate change and marine biodiversity loss. Various frameworks for integrating sectoral goals with each other and with environmental goals that could facilitate the transition towards Sustainable Blue Growth (SBG) already exist and have been suggested and promoted by the European Commission, such as Ecosystem-Based Management (EBM) and Marine Spatial Planning (MSP). They require the consideration of marine ecosystems and biodiversity and their protection as one of the BE sectors to be integrated via planning and management, which in turn requires the estimation of the value of ecosystem services and the spatial implications thereof. Nonetheless, there is little evidence or real-world examples on whether and how ecosystems, and within them coastal and marine biodiversity, are actually integrated (i.e., mainstreamed) when developing sectoral policies and planning and implementing economic activities at sea at various scales, i.e., local, national, and regional, and what the necessary steps and actions are that would facilitate such mainstreaming. By seeking evidence in EU and Atlantic Arc (AA) member states’ sectoral policies on marine tourism, ports and shipping, marine renewable energy, and fisheries and aquaculture (as promoted by the Atlantic Maritime Strategy and its corresponding action plans) and in the outcomes of the Interreg Atlantic Funded Research Project MOSES (aiming at valuating a Sustainable Blue Economy at the national and regional scale of the EU AA), the present article focused on understanding if and how marine biodiversity is taken into consideration by EU and AA BE and/or BG policies, strategies, and sectoral developments. Τhe selected sectoral policies demonstrate a good uptake of marine-ecosystem- and biodiversity-related challenges; however, at both the EU and the AA member-state level, it is unclear whether and how marine ecosystems and biodiversity are addressed as a separate BE sector. As such, we argue why and how Marine Biodiversity Mainstreaming (MBM) could address this gap, and hence it could contribute to planning, implementing, and managing maritime economic activities towards SBG at the Sea Basin level. This is demonstrated by illustrating the central role of MBM in enabling (and being further enabled by) the above integrative frameworks (i.e., MSP and EBM) and by presenting the key elements and actions required for such facilitation

Are children's vitamin D levels and BMI associated with antibody titers produced in response to 2014–2015 influenza vaccine?

Background: Vitamin D is an immunomodulating hormone, which has been associated with susceptibility to infectious diseases. Methods: Serum vitamin D levels in 135 children ages 3–17 y were measured at baseline and hemagglutinin influenza antibody titers were measured pre- and 21 d post influenza vaccination with live attenuated influenza vaccine (LAIV) or inactivated influenza vaccine (IIV). Height and weight were derived from the electronic medical record and were used to calculate body mass index (BMI). Results: Thirty-nine percent of children were ages 3–8 years; 75% were black, 34% were obese (BMI ≥ 95th percentile); vitamin D levels were >20 ng/ml in 55%. In linear regression analyses, post vaccination antibody titers for LAIV B lineages (B Brisbane and B Massachusetts) were significantly higher among those with lower vitamin D levels and among younger participants (P < 0.05). No associations between vitamin D levels and responses to LAIV A strains (A/H1N1 and A/H3N2) or to any IIV strains or lineages were found. Conclusion: Low vitamin D levels were associated with higher response to LAIV B lineages in the 2014–2015 LAIV, but not related to LAIV A or any IIV strains